Clinical Trials

LymphoidOther hematologic neoplasm

40 enrolled 11 charts

Lymphoma, Hematologic Neoplasms

NCT01848132 2018-09-19

Efficacy/Safety Study of R-CHOP vs Bortezomib-R-CAP for Young Patients With Diffuse Large B-cell Lymphoma With Poor IPI.

121 enrolled

Lymphoma, Lymphoma, Large B-Cell, Diffuse

NCT00376961 2017-11-06

S0601 Rituximab, Combination Chemotherapy, and Bortezomib Followed by Bortezomib Alone in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma

68 enrolled 9 charts

Lymphoma, Lymphoma, Mantle-Cell

NCT01323920 2017-05-30

Bortezomib-based GVHD Prophylaxis After Allogeneic Transplant for Patients Without Matched Related Donors

LymphoidMyeloidOther hematologic neoplasm

35 enrolled 9 charts

Leukemia, Lymphoma, Myelodysplastic Syndromes

NCT00262860 2016-05-09

Bortezomib and Gemcitabine Hydrochloride in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma

18 enrolled 8 charts

Hodgkin Disease, Lymphoma

NCT00740415 2016-03-16

ManteauRiBVD

39 enrolled

Lymphoma, Lymphoma, Mantle-Cell

NCT00958256 2015-04-13

Study of Bortezomib in Combination With Cyclophosphamide and Rituximab

22 enrolled 3 charts

Lymphoma, Lymphoma, Mantle-Cell

NCT00723658 2015-03-06

S0629, Observation or Combination Chemotherapy, Bortezomib, Thalidomide, and Rituximab Followed By Two Autologous Peripheral Blood Stem Cell Transplants in Treating Patients With Waldenstrom Macroglobulinemia

Phase 2 Withdrawn

Lymphoma, Waldenstrom Macroglobulinemia

NCT00513955 2014-11-05

Combination Chemotherapy With or Without Bortezomib in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma

50 enrolled

Lymphoma, Lymphoma, Mantle-Cell

NCT00851552 2014-07-21

Bortezomib, Doxorubicin Hydrochloride Liposome, and Rituximab in Treating Patients With Diffuse Large B-Cell Lymphoma That Has Relapsed or Not Responded to Treatment

9 enrolled 5 charts

Lymphoma, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic

NCT00045695 2013-05-17

Bortezomib in Treating Patients With Waldenstrom's Macroglobulinemia

27 enrolled

Lymphoma, Waldenstrom Macroglobulinemia

NCT00066508 2013-01-08

Bortezomib in Treating Patients With Diffuse Large B-Cell Lymphoma That Is Refractory To Chemotherapy

7 enrolled

Lymphoma, Lymphoma, Large B-Cell, Diffuse

NCT00093769 2012-10-04

Bortezomib and Rituximab in Treating Patients With Non-Hodgkin's Lymphoma

15 enrolled

Lymphoma, Lymphoma, Follicular, Lymphoma, B-Cell, Marginal Zone

NCT00054665 2012-09-11

PS-341 Alone and PS-341 Plus EPOCH Chemotherapy to Treat Non-Hodgkin's Lymphoma

50 enrolled 10 charts

Lymphoma, Lymphoma, B-Cell

NCT00810576 2012-08-07

Combination of Vorinostat and Bortezomib in Relapsed or Refractory T-Cell Non-Hodgkin's Lymphoma

1 enrolled 3 charts

DermatologicLymphoid

Subcutaneous panniculitis-like T-cell lymphoma, Immunoblastic Lymphadenopathy, Lymphoma, Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Enteropathy-Associated T-Cell Lymphoma

NCT00509379 2011-01-28

LYM-2023

48 enrolled

Lymphoma, Lymphoma, Non-Hodgkin, Recurrence

NCT00148018 2008-07-10

Study of Bortezomib (Velcade) in Combination With Dexamethasone to Treat Patients With Relapsed Hodgkin's Lymphoma

37 enrolled

Hodgkin Disease, Lymphoma, Recurrence

NCT00085696 2008-02-11

VELCADE® (Bortezomib) With Rituximab in Subjects With Relapsed or Refractory Indolent B-Cell Lymphoma

66 enrolled

Lymphoma, Lymphoma, Follicular, Lymphoma, B-Cell

NCT00265928 2008-01-28

Bortezomib and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma